MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about updates

13 Dec 2022 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Board of Directors have jointly authorized the enclosed personnel of the Company, for the purpose of determining the materiality of any event or transaction for the purpose of making disclosures.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..